World Maleria Day
World Malaria Day is observed on 25 April every year to recognize global efforts to fight malaria globally. The day is organized by the WHO and was established in the 60th session of the World Health Assembly in May 2007. The day was formed to present information and improves understanding of malaria and spread information on “year-long intensified implementation of national malaria-control strategies, including community-based activities for malaria prevention and treatment in endemic areas.”
The day was established to provide “education and understanding of malaria” and spread information on World Malaria Day 2020 WHO and RBM form a partnership to end malaria with the campaign “Zero malaria starts with me” a campaign aimed to keep malaria high on the political agenda, organize additional resources, and authorize local authorities to take ownership of prevention and care of the disease.
The report for 2019 shows that no substantial gains have been made in reducing the number of malaria cases between 2014 and 2018. The zero malaria campaign wants to engage more members in civil society from political leaders controlling governmental policy, the private sector that will benefit from a malaria-free workforce, and the local communities affected by malaria.
What is Malaria?
Malaria is a disease caused by a parasite. The parasite is transmitted by infected mosquitoes bites. the parasite causing malaria Plasmodium parasites and is spread through the bites of female Anopheles mosquitoes, called “malaria vectors”. The symptoms of the disease occur 10 to 15 days after being bitten by the infected mosquitoes. Children with severe malaria can have symptoms such as severe anemia and respiratory distress. Adults can go in multi-organ failure
Symptoms of malaria are:-
Fever
Chills
Headache
Nausea and vomiting
Muscle pain and fatigue.
There two major types of malaria in India Plasmodium vivax and Plasmodium falciparum Malaria is common in Asia, Africa, and South America.
To diagnose malaria the doctor will review your medical history, conduct a thorough physical exam. The doctor near me will order blood tests at home. The blood tests detect the type of malaria parasite and confirm the presence of the parasite.
Malaria is a preventable and treatable disease. If diagnosed early malaria can be treated with no complications. Treatment option depends on the severity of the disease, the type of parasite, and if ant malarial tablets were taken. The doctor near me may treat your condition with a combination of the drugs.
India has been showing declining trends of malaria from 2 million cases in 2001 to 1 million cases in 2017. India still has 90% of the cases in South East Asia. Global targets cannot be achieved without involving India.
The Government of India developed the National Framework of Malaria Elimination and National Strategic Plan (NSP, 2017-18) with the aim to eliminate malaria in Category 1 and category 2 districts in 2022. Category 3 or high transmission districts aims to bring it under pre-elimination status.
The NSP is initially targeting low and moderate transmission districts (Category 1 and category 2). Surveillance is an important part of the malaria elimination program aimed at assessing transmission and thereby ranking it for interventions and monitoring the impact of the intervention. Rapid Diagnostic Testing for people who live in malaria districts has improved diagnosis.
To prevent the spread of malaria you need to prevent mosquito bites. There are effective measures suggested by the government:-
Control Insect Breeding
Individual prevention
Prevention in control
Prevention during travel
Preventing malaria during pregnancy.
Scroll down for more posts ▼
Top 10 Most Recent News Articles
The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...
Continue Reading
Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...
Continue Reading
GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...
Continue Reading
Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...
Continue Reading
Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...
Continue Reading
Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....
Continue Reading
The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...
Continue Reading
Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...
Continue Reading
Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...
Continue Reading
Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...
Continue Reading
Top 5 Most Recently Viewed Articles
SKK Holdings Limited Announces Share Pricing for IPO SKK Holdings Limited (“SKK” or the “Company”) (Nasdaq: SKK), a specialized civil engineering service provider in subsurface utility works, has proudly announced the pricing of its initial public offering. The Company will offer 2,500,000 ordinary shares at a public offering price of $4.00 per share, yielding...
Continue Reading
Antelope Enterprise Holdings Limited (NASDAQ: AEHL) hit the financial report stage hard back in mid-2024, flaunting numbers that tell quite the tale of both triumphs and tribulations. This company was hustling across two growing fronts: the fast-paced world of livestreaming ecommerce and the burgeoning energy sector down in Texas. Their half-year performance review...
Continue Reading
Olivier Falut Joins EUROAPI as the New Chief Financial Officer EUROAPI is excited to announce the appointment of Olivier Falut as its new Chief Financial Officer, effective immediately. Olivier will be an integral member of the Executive Committee, succeeding Evelyne Nguyen. Evelyne will ensure continuity and a smooth transition within the company through her support...
Continue Reading
OPEXUS and Casepoint Unite for Strategic Growth In a significant development in the technology sector, OPEXUS, a frontrunner in government process management software, and Casepoint, an innovator in data discovery technology, have announced their merger. This significant move comes along with a majority investment from Thoma Bravo, a renowned software investment firm...
Continue Reading
MeiraGTx Holdings plc (NASDAQ:MGTX) was a clinical-stage gene therapy firm making waves back in 2024. The company announced a pivotal financial move, securing $50 million through equity financing at $4 per share, largely thanks to a $30 million investment from Sanofi (NYSE:SNY). While this funding boosted MGTX’s war chest, traders were already whispering about the heavy...
Continue Reading